Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Jan 31, 2015

Filed with the SEC on Mar 17, 2015 and accepted by EDGAR at Mar 17, 2015, 17:25 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-01-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2014-11-01 to 2015-01-31$1.1mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2014-05-01 to 2015-01-31$3.8mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-11-01 to 2015-01-31−$3.4mus-gaap:OperatingIncomeLoss
Operating income9 months2014-05-01 to 2015-01-31−$10.8mus-gaap:OperatingIncomeLoss
Income tax3 months2014-11-01 to 2015-01-31$12.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2014-05-01 to 2015-01-31$27.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-11-01 to 2015-01-31−$2.8mus-gaap:NetIncomeLoss
Net income9 months2014-05-01 to 2015-01-31−$9.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-11-01 to 2015-01-31−$0.05us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2014-05-01 to 2015-01-31−$0.16us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-11-01 to 2015-01-31−$0.04us-gaap:EarningsPerShareBasic
Basic EPS9 months2014-05-01 to 2015-01-31−$0.14us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-11-01 to 2015-01-3167,245,577 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2014-05-01 to 2015-01-3167,243,142 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2014-05-01 to 2015-01-31−$7.6mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure9 months2014-05-01 to 2015-01-31$84.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-01-31$182.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-01-31$1.5mus-gaap:AssetsCurrent
Total assetsAt period end2015-01-31$2.8mus-gaap:Assets
Current liabilitiesAt period end2015-01-31$6.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-01-31$7.0mus-gaap:Liabilities
Shareholders' equityAt period end2015-01-31−$4.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-15-016811. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.